The opportunity cost of automated glycopeptide analysis: case study profiling the SARS-CoV-2 S glycoprotein.

Volume: 413, Issue: 29, Pages: 7215 - 7227
Published: Aug 27, 2021
Abstract
Glycosylation analysis of viral glycoproteins contributes significantly to vaccine design and development. Among other benefits, glycosylation analysis allows vaccine developers to assess the impact of construct design or producer cell line choices for vaccine production, and it is a key measure by which glycoproteins that are produced for use in vaccination can be compared to their native viral forms. Because many viral glycoproteins are...
Paper Details
Title
The opportunity cost of automated glycopeptide analysis: case study profiling the SARS-CoV-2 S glycoprotein.
Published Date
Aug 27, 2021
Volume
413
Issue
29
Pages
7215 - 7227
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.